Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D. Following the departure of GSK CEO Emma ...

Harry Sommer has left Norwegian Cruise Line Holdings. Photo Credit: NCLH Norwegian Cruise Line Holdings said Thursday that CEO Harry Sommer has stepped down, replaced by former Subway and Burger King ...

I have spent more than three decades studying leadership excellence—how people perform at their best, why some leaders consistently move others to action, and why others fail even while holding power.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Sanofi is replacing Paul Hudson as CEO, the company announced Thursday, ...

Former GitHub CEO Thomas Dohmke has raised the largest-ever seed round for a dev tool startup, according to its lead backer, Felicis. The startup, Entire, has raised $60 million at a $300 million ...

Red Lobster’s CEO sat down with WSJ in 2024 to share how he plans to bring America’s oldest seafood chain back to the top. Photo Illustration: Alexandra Larkin Red Lobster’s chief executive said the ...

Chipotle CEO Scott Boatwright suggested in leaked audio that the company would begin focusing on customers who make more than $100,000 per year, indicating further price hikes. During a recent ...

Target CEO Michael Fiddelke is reshuffling his leadership team and making other changes shortly after stepping into the top job at the retailer that has struggled operationally. Rick Gomez, the ...

Nearly 11 months after Kroger's former CEO resigned from the company following an investigation into personal conduct, the Cincinnati-based grocery has announced a new person to the position.Made ...

Control and Alan Wake developer Remedy Entertainment has named Jean-Charles Gaudechon as its new CEO. The company’s board of directors announced the news with a post on its website today. Co-founder ...

I'm the writer for the Forbes C-Suite newsletter series. Executive leadership firm Russell Reynolds Associates writes about some of the benefits and drawbacks of the structure in a recent article.

Novartis CEO Vas Narasimhan saw his realized compensation swell by 30% in 2025, reaching 24.9 million Swiss francs ($32.4 million) as the Swiss pharma giant exceeded its long-term financial and ...